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Reply
We appreciate the interest of Dr. Isaaz for our work (1). In regard
to our initial analysis, we did not calculate the flow after the
minimal intervention in patients who presented with occluded
vessels, but further to this request this parameter was randomly
(every second) estimated in one-half (225) of these patients;
Thrombolysis In Myocardial Infarction (TIMI) flow grade 1 was
restored in 46.6%, TIMI flow grade 2 in 38.8%, and TIMI flow
grade 3 in 14.6%.
The imbalances in the baseline characteristics among groups
are related to the retrospective nonrandomized nature of our
study. Appropriate multivariable statistical analysis was per-
formed to account for these imbalances. For the same reason,
established parameters related to clinical outcomes were missing
as addressed in the extensive limitations paragraph. The influ-
ence of the baseline characteristics imbalances and missing
parameters on the results of the study remains speculative. For
example, during the review process, we were asked to perform
the analysis excluding the patients presenting with stent throm-
bosis. By doing so, no difference was observed in the resultant
independent predictors including large thrombus burden.
By no means could our results support the hypothesis that
immediate stenting can probably be avoided in many patients at
the acute phase of ST-segment elevation myocardial infarction
(STEMI) once flow has been restored using minimal intervention,
since all of our patients were stented during the index procedure.
Such an approach partly questions the well-established superiority
of bare-metal stents compared with balloon angioplasty (2–4), and
beyond the questionable efficacy it has logistical and financial
implications that would make it quite unlikely to be explored in a
randomized fashion. In our view, in a STEMI setting, optimization
of all periprocedural parameters, including thrombus management by
pharmacologic and mechanical means, is the appropriate way to
go forward.
*Georgios Sianos, MD, PhD
Michail I. Papafaklis, MD
Joost Daemen, MD
Sofia Vaina, MD
Carlos A. van Mieghem, MD
Ron T. van Domburg, PhD
Lampros K. Michalis, MD, MRCP
Patrick W. Serruys, MD, PhD, FACC
*Thoraxcenter Erasmus Medical Center
Dr Molewaterplein 40
Rotterdam
Netherlands
3015 GD
E-mail: g.sianos@erasmusmc.nl
doi:10.1016/j.jacc.2007.12.004
REFERENCES
1. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent throm-
bosis after routine use of drug-eluting stents in ST-segment elevation
myocardial infarction: the importance of thrombus burden. J Am Coll
Cardiol 2007;50:573–83.
2. Suryapranata H, van’t Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F.
Randomized comparison of coronary stenting with balloon angioplasty
in selected patients with acute myocardial infarction. Circulation 1998;
97:2502–5.
3. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or
without stent implantation for acute myocardial infarction. Stent
primary angioplasty in myocardial infarction study group. N Engl J Med
1999;341:1949–56.
4. Stone GW, Grines CL, Cox DA, et al., for the CADILLAC
Investigators. Comparison of angioplasty with stenting, with or without
abciximab, in acute myocardial infarction. N Engl J Med
2002;346:957–66.
Prophylactic Use of Hemodialysis
to Prevent Radiocontrast-Induced
Nephropathy
The Discussion Is Open Again!
Lee et al. (1) present very interesting results on the prophylactic
use of hemodialysis to prevent radiocontrast-induced nephropathy.
Unfortunately, the quality of their discussion falls behind the
quality of the data presented. The authors somehow fail to
mention that several randomized controlled studies have previously
failed to show an improvement of renal outcome by prophylactic
hemodialysis after radiocontrast media application and that a
recent meta-analysis of the controlled studies has revealed no
advantage of prophylactic hemodialysis with respect to outcome
(2). The failure to mention the previous controlled studies hin-
dered the authors to emphasize the differences between their study
and the ones previously done.
In contrast to previous studies including our own (2,3), the
authors were very careful to avoid intravascular volume depletion
during the prophylactic dialysis procedure. Not only was there no
ultrafiltration provided during dialysis, but saline was administered
at the beginning of the dialysis procedure to counteract expected
volume shifts out of the vascular space into the intracellular space
during dialysis. Although patients might have profited from the
careful volume control during the prophylactic dialysis session, it is
conceivable that the poor outcome of patients without dialysis
might have resulted from the lack of a comparable volume
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